Jaclynn A Meshanni (Jaclynn Andres, Jaclynn Meshanni)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Resistance Training

Cystic Fibrosis

Top Venues

Research square

Pharmacology research & perspectives

Annals of the New York Academy of Sciences

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren M Aleksunes, Joshua P Gray, Jaclynn A Meshanni, Jeffrey D Laskin, Debra L Laskin
Repurposing FDA-approved drugs to treat chemical weapon toxicities: Interactive case studies for trainees. Pharmacology research & perspectives 12 (4) (2024)
Elena N Atochina-Vasserman, Jaclynn A Meshanni, Emily R Stevenson, Dapeng Zhang, Rachel Sun, Nathan Ona, Erin K Reagan, Elena Abramova, Chang-Jiang Guo, Melissa Wilkinson, Ishana Baboo, Yuzi Yang, Liuyan Pan, Devendra S Maurya, Virgil Percec, Yongsheng Li, Andrew Gow, Drew Weissman
Targeted delivery of TGF-β mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers. Research square (2024)
Elena N Atochina-Vasserman, Jaclynn A Meshanni, Emily R Stevenson, Dapeng Zhang, Rachel Sun, Nathan Ona, Erin K Reagan, Elena Abramova, Chang-Jiang Guo, Melissa Wilkinson, Ishana Baboo, Yuzi Yang, Liuyan Pan, Devendra S Maurya, Virgil Percec, Yongsheng Li, Andrew Gow, Drew Weissman
Targeted delivery of TGF-β mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers. Research square (2024)
Elena N Atochina-Vasserman, Jaclynn A Meshanni, Emily R Stevenson, Dapeng Zhang, Rachel Sun, Nathan Ona, Erin K Reagan, Elena Abramova, Chang-Jiang Guo, Melissa Wilkinson, Ishana Baboo, Yuzi Yang, Liuyan Pan, Devendra S Maurya, Virgil Percec, Yongsheng Li, Andrew Gow, Drew Weissman
Targeted delivery of TGF-β mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers. Research square (2024)
Lauren M Aleksunes, Joshua P Gray, Jaclynn A Meshanni, Jeffrey D Laskin, Debra L Laskin
Repurposing FDA-approved drugs to treat chemical weapon toxicities: Interactive case studies for trainees. Pharmacology research & perspectives 12 (4) (2024)
Lauren M Aleksunes, Joshua P Gray, Jaclynn A Meshanni, Jeffrey D Laskin, Debra L Laskin
Repurposing FDA-approved drugs to treat chemical weapon toxicities: Interactive case studies for trainees. Pharmacology research & perspectives 12 (4) (2024)
Jaclynn A Meshanni, Jordan M Lee, Kinal N Vayas, Rachel Sun, Chenghui Jiang, Grace L Guo, Andrew J Gow, Jeffrey D Laskin, Debra L Laskin
Suppression of lung oxidative stress, inflammation and fibrosis following nitrogen mustard exposure by the selective farnesoid X receptor agonist obeticholic acid . The Journal of pharmacology and experimental therapeutics (2023)
Alexa Murray, Andrew J Gow, Alessandro Venosa, Jaclynn A Meshanni, Rama Malaviya, Derek Adler, Edward Yurkow, Jeffrey D Laskin, Debra L Laskin
Assessment of mustard vesicant lung injury and anti-TNF-α efficacy in rodents using live-animal imaging. Annals of the New York Academy of Sciences 1480 (1) (2020)